Company profile
Agentix Corp. CIK 1603345
Ticker
AGTX (OTC)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Dana Point, CA 92629
Fiscal year end
2026 (FY)
Key Financials
Revenue
—
Net income
-$485.6K
Total assets
$771
Total liabilities
$3.60M
Stockholders' equity
-$3.60M
Cash & equivalents
$771
Operating income
-$445.2K
Operating cash flow
-$108.5K
Capital expenditures
—
Fiscal year 2026, via 10-K filed 2026-07-01. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
466,443.8%
Equity / assets
-466,343.8%
CapEx / revenue
—
Operating cash flow / net income
0.22×
Derived from the fiscal year 2026 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2026
—
-$485.6K
$771
$3.60M
-$3.60M
2025
—
-$567.0K
$100.3K
$3.20M
-$3.10M
2024
—
-$585.2K
$106.4K
$2.67M
-$2.56M
2023
$0
-$1.37M
$261.4K
$2.51M
-$2.25M
2022
$1.2K
-$2.63M
$16.0K
$1.09M
-$1.08M
Company Details
SIC code
2836
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-10
Financials filed via
Form 10-K
filed 2026-07-01
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Dana Point, CA 92629
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:17 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.